“…Experimental studies demonstrated potentiation of the specifi c effects of some bioactive substances by immobilized hyaluronate-endo-β-N-acetylhexosaminidase (imHEA-HA), an hyaluronidase analogue playing the key role in HA metabolism [2,4]. This drug created by electron-beam synthesis nanotechnology is a virtually nontoxic compound with manifest systemic effects (in contrast to unmodifi ed enzyme), also effective in oral treatment [7,8,10], which is explained by its resistance to serum and tissue degradation factors [13,14] and proteolytic enzymes of the gastrointestinal tract [6,7].…”